Skip to content

Exploring the effects of exercise on gut flora in healthy individuals: a cross-sectional clinical study

Exploring the effects of exercise on gut flora in healthy individuals: a cross-sectional clinical study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100004
Enrollment
Unknown
Registered
2025-04-01
Start date
2024-09-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic associated fatty liver disease

Interventions

Sedentary group:None

Sponsors

Southern Medical University Southern Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for the exercise group: 1. Voluntary signing of informed consent; 2. Age 18-30 years old; 3. Male or female; 4. BMI 18.5-24 kg/m^2; 5. No less than 3 times per week of moderate-intensity to high-intensity exercise (i.e., the average heart rate of exercise is not less than (220-age) multiplied by 0.6 beats/min) in the preceding 3 months, with a total duration of exercise of no less than 150 minutes; Inclusion criteria for sedentary group: 1. Voluntary signing of informed consent; 2. Age 18-30 years old; 3. Male or female; 4. BMI 18.5-24 kg/m^2; 5. Long-term sedentary behavior in the previous 3 months without any exercise habit.

Exclusion criteria

Exclusion criteria: 1. Those who have taken hormones within 3 months; 2. Those who have taken oral antibiotics within 1 month; 3. Have taken drugs that may interfere with glucose and lipid metabolism (e.g. insulin, glibenclamide, indomethacin, phentolamine, furosemide, phenytoin sodium, etc.) and drugs that affect intestinal flora, such as probiotics and Chinese herbs, in the past 1 month; 4. Heavy alcohol consumption (more than 30g of alcohol per day for men and more than 20g of alcohol per day for women) for more than 6 months; 5. Combined acute and chronic hepatitis and cirrhosis; 6. Combined chronic inflammatory diseases of the intestinal tract, acute infections; 7. Combined malignant tumors or other serious diseases; 8. Those who are losing weight; 9. Pregnant and lactating women; 10. Cardiac and renal insufficiency; 11. Persons with mental disorders; 12. In the judgment of the investigator, participation in this study is deemed unsuitable.

Design outcomes

Primary

MeasureTime frame
Microbiota in feces;

Secondary

MeasureTime frame
Metabolites in blood and feces;

Countries

China

Contacts

Public ContactSun Jian

Southern Medical University Southern Hospital

doctorsunjian@qq.com+86 20 62787432

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026